What other drugs are combined with ruxolitinib in apotex's formulation?

Short answer: Apotex does not market a fixed-dose combination of ruxolitinib with another active drug. Their ruxolitinib product is a single-ingredient tablet (ruxolitinib, typically as the phosphate salt in some markets).

If you’ve seen a label claiming “ruxolitinib + [another drug],” it’s not Apotex’s standard product. For exact formulation details (excipients, tablet strength, etc.) you’d need the specific product labeling from the country where it’s sold.

If you can share the country or the exact product code/name, I can help verify the official labeling and confirm whether it’s a single-ingredient product or a fixed-dose combination.